Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Colorectal Neoplasms

Free Subscription Articles published in Cancer Retrieve available abstracts of 46 articles: HTML format

Single Articles

January 2026
1. ALATISE OI, Owoade IA, Fayenuwo OJ, Lawal NOO, et al
   Customized early detection of colorectal cancer in Nigeria identifies advanced adenomas and early-stage disease.
   Cancer. 2026;132:e70156.
   PubMed     Abstract available
   
   
   December 2025
2. FANG J, Zheng Z, Chen T, Liu J, et al
   Efficacy and safety of PD-L1 blockade envafolimab as neoadjuvant treatment in mismatch repair-deficient, locally advanced colorectal cancer: An open-label, single-arm study.
   Cancer. 2025;131:e70203.
   PubMed     Abstract available
   
   
   
3. MYERS S, Davis ES, Franks JA, Davids JS, et al
   Beyond composite measures of regional vulnerability: Rural-urban colorectal cancer mortality disparities mediated by area-level characteristics.
   Cancer. 2025;131:e70098.
   PubMed     Abstract available
   
   
   October 2025
4. FOLKERTS AD, Janczewski LM, Merkow RP
   Liver-directed therapies for colorectal liver metastases.
   Cancer. 2025;131:e70097.
   PubMed     Abstract available
   
   
   
5. CORONADO GD, Gautom P, Schneider JL, Edelmann AC, et al
   Multilevel challenges and adaptations to patient navigation programs for colorectal cancer screening and follow-up: Findings from the Accelerating Colorectal Cancer Screening and follow-up through Implementation Science consortium.
   Cancer. 2025;131:e70121.
   PubMed     Abstract available
   
   
   
6. BUCHLER T, Ambrozova M, Majek O, Dianova T, et al
   Risk of second primary malignancies after adjuvant chemotherapy for colon cancer.
   Cancer. 2025;131:e70116.
   PubMed     Abstract available
   
   
   
7. KO B, Rojanasopondist P, Grady WM
   Top advances of the year: Noninvasive colorectal cancer screening tests.
   Cancer. 2025;131:e70115.
   PubMed     Abstract available
   
   
   September 2025
8. STEVENS SX, Gyawali B
   CodeBreaK or code blue? Assessing sotorasib's vital signs in metastatic colorectal cancer.
   Cancer. 2025;131:e70056.
   PubMed     Abstract available
   
   
   August 2025
9. TANGKA FKL, Ruiz E, Ibarra R, Hudson SM, et al
   Effectiveness and cost of implementing a patient navigation program to increase colorectal cancer screening in a large federally qualified health center.
   Cancer. 2025;131:e70031.
   PubMed     Abstract available
   
   
   
10. NIERENGARTEN MB
    Colorectal cancer treatments show promise: Studies find longer progression-free survival and a potential relative reduction in the risk of death with treatment advances.
    Cancer. 2025;131:e70000.
    PubMed    
    
    
    July 2025
11. SCHULTZ KS, Bansal VV, Wach MM, Bhutiani N, et al
    Consensus guideline for the management of colorectal cancer with peritoneal metastases.
    Cancer. 2025;131:e35869.
    PubMed     Abstract available
    
    
    May 2025
12. NIERENGARTEN MB
    Potential new standard of care for the first-line treatment of metastatic colorectal cancer: Interim analyses showed significantly better progression-free survival outcomes with the combination regimen versus either chemotherapy alone or nivolumab alo
    Cancer. 2025;131:e35854.
    PubMed    
    
    
    
13. STIMPSON JP, Liao JM, Morenz AM, Joo JH, et al
    A difference-in-differences analysis of Medicaid expansion and state paid sick leave laws on colorectal cancer screening.
    Cancer. 2025;131:e35904.
    PubMed     Abstract available
    
    
    
14. NIERENGARTEN MB
    Calcium may help to protect against colorectal cancer.
    Cancer. 2025;131:e35827.
    PubMed    
    
    
    
15. LEE S, Ma C, Caan BJ, Binder AM, et al
    Impact of resistance training on inflammatory biomarkers and associations with treatment outcomes in colon cancer.
    Cancer. 2025;131:e35865.
    PubMed     Abstract available
    
    
    April 2025
16. SUAREZ-RAMOS T, Verganza S, Pagan-Santana Y, Castaneda-Avila MA, et al
    Evaluating the impact of hurricanes and the COVID-19 pandemic on colorectal cancer incidence in Puerto Rico: An interrupted time-series analysis.
    Cancer. 2025;131:e35793.
    PubMed     Abstract available
    
    
    
17. MACHIDA N, Okumura T, Boku N, Kishimoto J, et al
    A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G).
    Cancer. 2025;131:e35807.
    PubMed     Abstract available
    
    
    
18. CLARKE N, Mooney T, Gallagher P, von Wagner C, et al
    Interventions to increase uptake in a fecal-immunochemical test population-based colorectal cancer screening program: A quasi-experimental study of first-time invitees.
    Cancer. 2025;131:e35760.
    PubMed     Abstract available
    
    
    March 2025
19. RAYCHAUDHURI S, McLaughlin E, Pennell ML, Stefanick M, et al
    The relationship between cardiometabolic abnormalities and mortality in the Women's Health Initiative: A comparison of associations among women with cancer to women without cancer.
    Cancer. 2025;131:e35804.
    PubMed     Abstract available
    
    
    
20. VOGTMANN E, Yano Y, Zouiouich S, Hua X, et al
    The human oral microbiome and risk of colorectal cancer within three prospective cohort studies in the United States.
    Cancer. 2025;131:e35802.
    PubMed     Abstract available
    
    
    
21. BROWN JC, Ma C, Shi Q, Saltz LB, et al
    The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance).
    Cancer. 2025;131:e35727.
    PubMed     Abstract available
    
    
    February 2025
22. ESLINGER C, Walden D, McGary A, Emiloju O, et al
    Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy.
    Cancer. 2025;131:e35756.
    PubMed     Abstract available
    
    
    
23. BAEKER BISPO J, Jemal A, Islami F
    Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression.
    Cancer. 2025;131:e35724.
    PubMed     Abstract available
    
    
    January 2025
24. PASSMAN JE, Kallan MJ, Roberson JL, Ginzberg SP, et al
    Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies.
    Cancer. 2025;131:e35664.
    PubMed     Abstract available
    
    
    
25. NORIEGA ESQUIVES BS, Moreno PI, Munoz E, Lad TE, et al
    Effects of a culturally tailored patient navigation program on unmet supportive care needs in Hispanic/Latino cancer survivors: A randomized controlled trial.
    Cancer. 2025;131:e35626.
    PubMed     Abstract available
    
    
    
26. PANDEY AS, Drogan C, Huo D, Postula K, et al
    Anticipation in families with MLH1-associated Lynch syndrome.
    Cancer. 2025;131:e35589.
    PubMed     Abstract available
    
    
    December 2024
27. NIERENGARTEN MB
    Colorectal cancer screening and prevention: Efforts aim to optimize colonoscopy measures and broaden accessibility to screening in underserved areas.
    Cancer. 2024;130:3945.
    PubMed    
    
    
    November 2024
28. CHAI TS, Rodgers-Fouche LH, Walls JO, Mattia AR, et al
    Real-world genetic testing outcomes of pan-cancer testing for mismatch repair deficiency.
    Cancer. 2024;130:3888-3893.
    PubMed     Abstract available
    
    
    
29. DESAI P, Zhou Y, Grenet J, Handelman SK, et al
    Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality.
    Cancer. 2024;130:3879-3887.
    PubMed     Abstract available
    
    
    October 2024
30. COMPTON SLE, Yang S, Madere J, Weltzien EK, et al
    Dietary quality and chemotherapy-induced peripheral neuropathy in colon cancer.
    Cancer. 2024 Oct 5. doi: 10.1002/cncr.35599.
    PubMed     Abstract available
    
    
    
31. SHI KS, Han X, Star J, Zhao J, et al
    Association of health insurance coverage disruptions and breast and colorectal cancer screening.
    Cancer. 2024 Oct 1. doi: 10.1002/cncr.35584.
    PubMed     Abstract available
    
    
    September 2024
32. BHUTIANI N, Peacock O, Uppal A, Hu CY, et al
    The prognostic impact of tumor deposits in colorectal cancer: More than just N1c.
    Cancer. 2024 Sep 22. doi: 10.1002/cncr.35491.
    PubMed     Abstract available
    
    
    
33. HE MM, Wang K, Song M
    Reply to "The influence of multivitamin intake on survival patterns in patients with colorectal cancer".
    Cancer. 2024 Sep 15. doi: 10.1002/cncr.35569.
    PubMed    
    
    
    
34. TANG WZ, Tang Y, Liu TH
    The influence of multivitamin intake on survival patterns in patients with colorectal cancer.
    Cancer. 2024 Sep 14. doi: 10.1002/cncr.35570.
    PubMed    
    
    
    August 2024
35. BEATRICI E, Paciotti M, Nguyen DD, Filipas DK, et al
    Estimating the impact of enhanced care at minority-serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers.
    Cancer. 2024;130:2770-2781.
    PubMed     Abstract available
    
    
    
36. ISSAKA RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, et al
    Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
    Cancer. 2024 Aug 9. doi: 10.1002/cncr.35514.
    PubMed     Abstract available
    
    
    
37. NIERENGARTEN MB
    Potential new therapy for KRAS-mutated CRC.
    Cancer. 2024;130:2569.
    PubMed    
    
    
    July 2024
38. SUN V, Guthrie KA, Crane TE, Arnold KB, et al
    SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.
    Cancer. 2024;130:2384-2394.
    PubMed     Abstract available
    
    
    May 2024
39. MARTINEZ ME, Roesch S, Largaespada V, Castaneda SF, et al
    A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low-income and minoritized populations.
    Cancer. 2024 May 25. doi: 10.1002/cncr.35369.
    PubMed     Abstract available
    
    
    
40. HOEHN RS, Ammori JB, Rothermel LD, Winter JM, et al
    Providing context for the HIPECT4 results.
    Cancer. 2024;130:1727-1729.
    PubMed    
    
    
    
41. JANCZEWSKI LM, Browner A, Cotler J, Nelson H, et al
    Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
    Cancer. 2024;130:1702-1710.
    PubMed     Abstract available
    
    
    April 2024
42. SIMONI O, Scarpa M, Castagliuolo I, Stepanyan A, et al
    IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.
    Cancer. 2024 Apr 22. doi: 10.1002/cncr.35297.
    PubMed     Abstract available
    
    
    
43. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    PubMed    
    
    
    
44. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    PubMed    
    
    
    February 2024
45. LIU YL, Weigelt B
    A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Cancer. 2024 Feb 29. doi: 10.1002/cncr.35267.
    PubMed     Abstract available
    
    
    November 2023
46. YANG K, Doege D, Thong MSY, Koch-Gallenkamp L, et al
    Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study.
    Cancer. 2023 Nov 23. doi: 10.1002/cncr.35133.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.